|Outcomes||Losartan||Atenolol||RRR (95% CI)||NNT (CI)|
|*Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article.|
|†Cardiovascular mortality, stroke, and myocardial infarction.|
|Composite end point†||11%||13%||12% (2 to 22)||64 (36 to 418)|
|Stroke||5%||7%||24% (11 to 36)||61 (42 to 140)|
|New onset diabetes||6%||8%||24% (12 to 36)||52 (35 to 108)|
Losartan reduced stroke and new onset diabetes more than atenolol in essential hypertension with signs of left ventricular hypertrophy
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>
EBN Online Journal Club
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.